Hansoh Pharmaceutical Group Company Limited (FRA:3KY)

Germany flag Germany · Delayed Price · Currency is EUR
4.000
+0.200 (5.26%)
At close: Sep 30, 2025
5.26%
Market Cap23.91B
Revenue (ttm)1.57B
Net Income (ttm)568.30M
Shares Outn/a
EPS (ttm)0.10
PE Ratio42.08
Forward PE38.58
Dividend0.04 (1.06%)
Ex-Dividend DateSep 22, 2025
Volumen/a
Average Volume3,052
Open3.860
Previous Close3.800
Day's Range3.860 - 4.000
52-Week Range1.970 - 4.220
Betan/a
RSI46.28
Earnings DateNov 18, 2025

About FRA:3KY

Hansoh Pharmaceutical Group Company Limited, an investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China. The company provides products for therapeutic areas, including anti-infection, central nervous system, oncology, and metabolic and other diseases, as well as autoimmune diseases. Its principal products include Ameile, Hansoh Xinfu, Pulaile, Zefei, Xintai, Xinmei, Gainuo, Tanneng, and Pulaitan; Hengmu, Mailingda, Hengsen, Oulanning, Ailanning, and Amei... [Read more]

Industry Pharmaceutical Preparations
Founded 1995
Employees 8,989
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 3KY
Full Company Profile

Financial Performance

In 2024, FRA:3KY's revenue was 12.26 billion, an increase of 21.35% compared to the previous year's 10.10 billion. Earnings were 4.37 billion, an increase of 33.39%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.